Kreft, S., Glutsch, V., Zaremba, A., Schummer, P., Mohr, P., Grimmelmann, I., Gutzmer, R., Meier, F., Pföhler, C., Sachse, M. M., Meiss, F., Forschner, A., Haferkamp, S., Welzel, J., Terheyden, P., Herbst, R., Utikal, J., Kaatz, M., Weishaupt, C., Kreuter, A., Debus, D., Duecker, P., Sindrilaru, A., Löffler, H., Schley, G., Weichenthal, M., Schadendorf, D., Ugurel, S., Gesierich, A., & Schilling, B. (2022). mAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. European journal of cancer, 167, 32–41. http://access.bl.uk/ark:/81055/vdc_100153812128.0x000024